APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Anthranilamide

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Anthranilamide Market Outlook and Growth Opportunities 2026

27 December 2025199 pages

Choose your research edition.

Industry ResearchAnthranilamide Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Anthranilamide Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Anthranilamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anthranilamide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Anthranilamide Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Anthranilamide market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Anthranilamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anthranilamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anthranilamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Anthranilamide market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Anthranilamide market include Alchemo Industries, Biosynth, Kavya Pharma and Sarex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anthranilamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anthranilamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anthranilamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anthranilamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Anthranilamide Segment by Company

Alchemo Industries

Biosynth

Kavya Pharma

Sarex

Anthranilamide Segment by Type

0.99

0.98

Anthranilamide Segment by Application

Medicine

Spices

Pesticide

Chemical

Others

Anthranilamide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Anthranilamide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Anthranilamide market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Anthranilamide significant trends, drivers, influence factors in global and regions.

6. To analyze Anthranilamide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anthranilamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anthranilamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anthranilamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anthranilamide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anthranilamide industry.

Chapter 3: Detailed analysis of Anthranilamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Anthranilamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Anthranilamide in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Anthranilamide Industry Trends Table 2. Anthranilamide Industry Drivers Table 3. Anthranilamide Industry Opportunities and Challenges Table 4. Anthranilamide Industry Restraints Table 5. Global Anthranilamide Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Anthranilamide Revenue Share by Company (2021-2026) Table 7. Global Anthranilamide Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Anthranilamide Sales Volume Share by Company (2021-2026) Table 9. Global Anthranilamide Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Anthranilamide Company Ranking, (2024-2026) & (USD Million) Table 11. Global Anthranilamide Key Company Manufacturing Base & Headquarters Table 12. Global Anthranilamide Company, Product Type & Application Table 13. Global Anthranilamide Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Anthranilamide by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.99 Table 18. Significant Companies of 0.98 Table 19. Global Anthranilamide Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Anthranilamide Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Anthranilamide Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Anthranilamide Sales Volume Share by Type (2021-2026) Table 23. Global Anthranilamide Sales Volume Share by Type (2027-2032) Table 24. Global Anthranilamide Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Anthranilamide Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Anthranilamide Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Anthranilamide Sales Value Share by Type (2021-2026) Table 28. Global Anthranilamide Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medicine Table 30. Significant Companies of Spices Table 31. Significant Companies of Pesticide Table 32. Significant Companies of Chemical Table 33. Significant Companies of Others Table 34. Global Anthranilamide Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 35. Global Anthranilamide Sales Volume by Application (2021-2026) & (Tons) Table 36. Global Anthranilamide Sales Volume by Application (2027-2032) & (Tons) Table 37. Global Anthranilamide Sales Volume Share by Application (2021-2026) Table 38. Global Anthranilamide Sales Volume Share by Application (2027-2032) Table 39. Global Anthranilamide Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Anthranilamide Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Anthranilamide Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Anthranilamide Sales Value Share by Application (2021-2026) Table 43. Global Anthranilamide Sales Value Share by Application (2027-2032) Table 44. Global Anthranilamide Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 45. Global Anthranilamide Sales by Region (2021-2026) & (Tons) Table 46. Global Anthranilamide Sales Market Share by Region (2021-2026) Table 47. Global Anthranilamide Sales by Region (2027-2032) & (Tons) Table 48. Global Anthranilamide Sales Market Share by Region (2027-2032) Table 49. Global Anthranilamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Anthranilamide Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Anthranilamide Sales Value Share by Region (2021-2026) Table 52. Global Anthranilamide Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Anthranilamide Sales Value Share by Region (2027-2032) Table 54. Global Anthranilamide Market Average Price (US$/Ton) by Region (2021-2026) Table 55. Global Anthranilamide Market Average Price (US$/Ton) by Region (2027-2032) Table 56. Global Anthranilamide Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 57. Global Anthranilamide Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Anthranilamide Sales by Country (2021-2026) & (Tons) Table 59. Global Anthranilamide Sales Market Share by Country (2021-2026) Table 60. Global Anthranilamide Sales by Country (2027-2032) & (Tons) Table 61. Global Anthranilamide Sales Market Share by Country (2027-2032) Table 62. Global Anthranilamide Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Anthranilamide Sales Value Market Share by Country (2021-2026) Table 64. Global Anthranilamide Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Anthranilamide Sales Value Market Share by Country (2027-2032) Table 66. Alchemo Industries Company Information Table 67. Alchemo Industries Business Overview Table 68. Alchemo Industries Anthranilamide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 69. Alchemo Industries Anthranilamide Product Portfolio Table 70. Alchemo Industries Recent Development Table 71. Biosynth Company Information Table 72. Biosynth Business Overview Table 73. Biosynth Anthranilamide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Biosynth Anthranilamide Product Portfolio Table 75. Biosynth Recent Development Table 76. Kavya Pharma Company Information Table 77. Kavya Pharma Business Overview Table 78. Kavya Pharma Anthranilamide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Kavya Pharma Anthranilamide Product Portfolio Table 80. Kavya Pharma Recent Development Table 81. Sarex Company Information Table 82. Sarex Business Overview Table 83. Sarex Anthranilamide Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Sarex Anthranilamide Product Portfolio Table 85. Sarex Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. Anthranilamide Distributors List Table 89. Anthranilamide Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Anthranilamide Product Image Figure 2. Global Anthranilamide Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anthranilamide Sales Value (2021-2032) & (US$ Million) Figure 4. Global Anthranilamide Sales (2021-2032) & (Tons) Figure 5. Global Anthranilamide Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Anthranilamide Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.99 Image Figure 10. 0.98 Image Figure 11. Global Anthranilamide Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Anthranilamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Anthranilamide Sales Volume Share by Type (2021-2032) Figure 14. Global Anthranilamide Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Anthranilamide Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Anthranilamide Sales Value Share by Type (2021-2032) Figure 17. Medicine Image Figure 18. Spices Image Figure 19. Pesticide Image Figure 20. Chemical Image Figure 21. Others Image Figure 22. Global Anthranilamide Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Anthranilamide Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Anthranilamide Sales Volume Share by Application (2021-2032) Figure 25. Global Anthranilamide Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Anthranilamide Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Anthranilamide Sales Value Share by Application (2021-2032) Figure 28. Global Anthranilamide Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Anthranilamide Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Anthranilamide Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Anthranilamide Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Anthranilamide Sales Value (2021-2032) & (US$ Million) Figure 33. North America Anthranilamide Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Anthranilamide Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Anthranilamide Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Anthranilamide Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Anthranilamide Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Anthranilamide Sales Value (2021-2032) & (US$ Million) Figure 39. South America Anthranilamide Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Anthranilamide Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Anthranilamide Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Anthranilamide Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Anthranilamide Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Anthranilamide Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Anthranilamide Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Anthranilamide Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 0.99
  • 0.98
Applications
  • Medicine
  • Spices
  • Pesticide
  • Chemical
  • Others
Companies covered
  • Alchemo Industries
  • Biosynth
  • Kavya Pharma
  • Sarex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anthranilamide Sales Value (2021-2032)
  4. 1.2.2 Global Anthranilamide Sales Volume (2021-2032)
  5. 1.2.3 Global Anthranilamide Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Anthranilamide Market Dynamics
  1. 2.1 Anthranilamide Industry Trends
  2. 2.2 Anthranilamide Industry Drivers
  3. 2.3 Anthranilamide Industry Opportunities and Challenges
  4. 2.4 Anthranilamide Industry Restraints
3 Anthranilamide Market by Company
  1. 3.1 Global Anthranilamide Company Revenue Ranking in 2025
  2. 3.2 Global Anthranilamide Revenue by Company (2021-2026)
  3. 3.3 Global Anthranilamide Sales Volume by Company (2021-2026)
  4. 3.4 Global Anthranilamide Average Price by Company (2021-2026)
  5. 3.5 Global Anthranilamide Company Ranking (2024-2026)
  6. 3.6 Global Anthranilamide Company Manufacturing Base and Headquarters
  7. 3.7 Global Anthranilamide Company Product Type and Application
  8. 3.8 Global Anthranilamide Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Anthranilamide Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Anthranilamide Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Anthranilamide Market by Type
  1. 4.1 Anthranilamide Type Introduction
  2. 4.1.1 0.99
  3. 4.1.2 0.98
  4. 4.2 Global Anthranilamide Sales Volume by Type
  5. 4.2.1 Global Anthranilamide Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anthranilamide Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Anthranilamide Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Anthranilamide Sales Value by Type
  9. 4.3.1 Global Anthranilamide Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anthranilamide Sales Value by Type (2021-2032)
  11. 4.3.3 Global Anthranilamide Sales Value Share by Type (2021-2032)
5 Anthranilamide Market by Application
  1. 5.1 Anthranilamide Application Introduction
  2. 5.1.1 Medicine
  3. 5.1.2 Spices
  4. 5.1.3 Pesticide
  5. 5.1.4 Chemical
  6. 5.1.5 Others
  7. 5.2 Global Anthranilamide Sales Volume by Application
  8. 5.2.1 Global Anthranilamide Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Anthranilamide Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Anthranilamide Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Anthranilamide Sales Value by Application
  12. 5.3.1 Global Anthranilamide Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Anthranilamide Sales Value by Application (2021-2032)
  14. 5.3.3 Global Anthranilamide Sales Value Share by Application (2021-2032)
6 Anthranilamide Regional Sales and Value Analysis
  1. 6.1 Global Anthranilamide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anthranilamide Sales by Region (2021-2032)
  3. 6.2.1 Global Anthranilamide Sales by Region: 2021-2026
  4. 6.2.2 Global Anthranilamide Sales by Region (2027-2032)
  5. 6.3 Global Anthranilamide Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Anthranilamide Sales Value by Region (2021-2032)
  7. 6.4.1 Global Anthranilamide Sales Value by Region: 2021-2026
  8. 6.4.2 Global Anthranilamide Sales Value by Region (2027-2032)
  9. 6.5 Global Anthranilamide Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Anthranilamide Sales Value (2021-2032)
  12. 6.6.2 North America Anthranilamide Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Anthranilamide Sales Value (2021-2032)
  15. 6.7.2 Europe Anthranilamide Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Anthranilamide Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Anthranilamide Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Anthranilamide Sales Value (2021-2032)
  21. 6.9.2 South America Anthranilamide Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Anthranilamide Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Anthranilamide Sales Value Share by Country, 2025 VS 2032
7 Anthranilamide Country-level Sales and Value Analysis
  1. 7.1 Global Anthranilamide Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Anthranilamide Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Anthranilamide Sales by Country (2021-2032)
  4. 7.3.1 Global Anthranilamide Sales by Country (2021-2026)
  5. 7.3.2 Global Anthranilamide Sales by Country (2027-2032)
  6. 7.4 Global Anthranilamide Sales Value by Country (2021-2032)
  7. 7.4.1 Global Anthranilamide Sales Value by Country (2021-2026)
  8. 7.4.2 Global Anthranilamide Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Anthranilamide Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Anthranilamide Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Anthranilamide Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Anthranilamide Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Anthranilamide Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Anthranilamide Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Anthranilamide Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Anthranilamide Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Anthranilamide Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Anthranilamide Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Anthranilamide Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Anthranilamide Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Anthranilamide Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Anthranilamide Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Anthranilamide Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Anthranilamide Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Anthranilamide Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Anthranilamide Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Anthranilamide Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Anthranilamide Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Anthranilamide Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Anthranilamide Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Anthranilamide Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Anthranilamide Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Anthranilamide Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Anthranilamide Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Anthranilamide Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Anthranilamide Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Anthranilamide Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Anthranilamide Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Anthranilamide Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Anthranilamide Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Anthranilamide Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Anthranilamide Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Anthranilamide Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Anthranilamide Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Anthranilamide Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Anthranilamide Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Anthranilamide Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Anthranilamide Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Anthranilamide Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Anthranilamide Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Anthranilamide Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Anthranilamide Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Anthranilamide Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Anthranilamide Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Anthranilamide Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Anthranilamide Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Anthranilamide Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Anthranilamide Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Anthranilamide Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Anthranilamide Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Anthranilamide Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Anthranilamide Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Anthranilamide Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Anthranilamide Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Anthranilamide Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Anthranilamide Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Anthranilamide Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Anthranilamide Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Anthranilamide Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Anthranilamide Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Anthranilamide Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Anthranilamide Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Anthranilamide Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Anthranilamide Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Anthranilamide Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Anthranilamide Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Anthranilamide Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Anthranilamide Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Anthranilamide Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Anthranilamide Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Anthranilamide Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Anthranilamide Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Anthranilamide Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Anthranilamide Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Anthranilamide Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Anthranilamide Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Anthranilamide Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Anthranilamide Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Anthranilamide Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Anthranilamide Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Anthranilamide Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Anthranilamide Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alchemo Industries
  2. 8.1.1 Alchemo Industries Company Information
  3. 8.1.2 Alchemo Industries Business Overview
  4. 8.1.3 Alchemo Industries Anthranilamide Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alchemo Industries Anthranilamide Product Portfolio
  6. 8.1.5 Alchemo Industries Recent Developments
  7. 8.2 Biosynth
  8. 8.2.1 Biosynth Company Information
  9. 8.2.2 Biosynth Business Overview
  10. 8.2.3 Biosynth Anthranilamide Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biosynth Anthranilamide Product Portfolio
  12. 8.2.5 Biosynth Recent Developments
  13. 8.3 Kavya Pharma
  14. 8.3.1 Kavya Pharma Company Information
  15. 8.3.2 Kavya Pharma Business Overview
  16. 8.3.3 Kavya Pharma Anthranilamide Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Kavya Pharma Anthranilamide Product Portfolio
  18. 8.3.5 Kavya Pharma Recent Developments
  19. 8.4 Sarex
  20. 8.4.1 Sarex Company Information
  21. 8.4.2 Sarex Business Overview
  22. 8.4.3 Sarex Anthranilamide Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sarex Anthranilamide Product Portfolio
  24. 8.4.5 Sarex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anthranilamide Value Chain Analysis
  2. 9.1.1 Anthranilamide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anthranilamide Sales Mode & Process
  6. 9.2 Anthranilamide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anthranilamide Distributors
  9. 9.2.3 Anthranilamide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst